Epitomee Medical Ltd (TLV: EPIT)

Epitomee Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	10	10	-
Gross Profit	10	10	-
Selling, General & Admin	3.37	2.79	3.28
Research & Development	5.83	6.8	7.79
Operating Expenses	2.16	9.58	11.07
Operating Income	7.84	0.42	-11.07
Interest Expense	-	-0.06	-
Interest & Investment Income	2.47	1.6	0.48
Currency Exchange Gain (Loss)	-0.46	-0.46	-4.9
Other Non Operating Income (Expenses)	-0.01	-0.01	0.1
EBT Excluding Unusual Items	9.84	1.5	-15.39
Asset Writedown	-7.18	-7.18	-
Pretax Income	2.66	-5.68	-15.39
Net Income	2.66	-5.68	-15.39
Net Income to Common	2.66	-5.68	-15.39
Shares Outstanding (Basic)	30	30	29
Shares Outstanding (Diluted)	31	30	29
Shares Change (YoY)	4.96%	0.70%	-
EPS (Basic)	0.09	-0.19	-0.52
EPS (Diluted)	0.09	-0.19	-0.52
Free Cash Flow	-11.99	-12	-13.12
Free Cash Flow Per Share	-0.39	-0.40	-0.45
Gross Margin	100.00%	100.00%	-
Operating Margin	78.38%	4.16%	-
Profit Margin	26.64%	-56.82%	-
Free Cash Flow Margin	-119.87%	-119.96%	-
EBITDA	7.88	0.63	-11.01
EBITDA Margin	78.82%	6.30%	-
D&A For EBITDA	0.04	0.21	0.06
EBIT	7.84	0.42	-11.07
EBIT Margin	78.38%	4.16%	-

Source: S&P Capital IQ. Standard template. Financial Sources.